Coronary and Peripheral Stents Market Size to Reach US$ 20.23 Billion by 2033

The Coronary and Peripheral Stents Market size was valued at US$ 9,327.81 million in 2024 and is projected to reach US$ 20,230.87 million by 2033, registering a CAGR of 8.98% from 2025 to 2033. Rising prevalence of cardiovascular disease, growing adoption of drug-eluting stents, and a preference for minimally invasive interventions are supporting market growth. Technological advances in stent design, dedicated stents for complex anatomies, and expanding access in Asia Pacific are creating new opportunities for medical device manufacturers and cardiovascular care providers.

Market Overview

The Coronary and Peripheral Stents Market is evolving as interventional cardiologists and vascular specialists increasingly use stents in minimally invasive procedures that restore blood flow and relieve symptoms in patients with blocked arteries. The market is segmented by product type into Bare-Metal Stents, Drug-Eluting Stents, Bioresorbable Vascular Scaffolds, and Others; by material type into Metal, Polymer, and Hybrid; by application into Coronary Artery Disease and Peripheral Artery Disease; and by end user into Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Labs, and Specialty Clinics.

The drug-eluting stents segment dominated the market by product type in 2024, the metal segment dominated by material type, the coronary artery disease segment held the larger share by application, and the hospitals segment held the largest share by end user. Asia Pacific is expected to grow significantly during the forecast period.

Check valuable insights in the Coronary and Peripheral Stents Market report. You can easily get a sample PDF of the report – https://www.businessmarketinsights.com/sample/BMIPUB00031925

Key Market Trends

Drug-Eluting Stents Lead Product Types
The drug-eluting stents segment dominated the market in 2024. These stents slowly release medication that helps prevent re-narrowing of the artery, leading to better long-term patient outcomes than bare-metal stents.

Metal Leads Material Types
The metal segment dominated the market in 2024. Metal stents offer superior mechanical strength, durability, and a low rate of fracture, and materials such as cobalt-chromium allow thinner struts that improve flexibility and biocompatibility.

Coronary Artery Disease Leads Applications
The coronary artery disease segment held the larger share in 2024, as the disease is a major cause of death worldwide and stents are a primary treatment.

Hospitals Lead End Users
The hospitals segment held the largest share in 2024 because stent implantation is a complex procedure performed by specialized interventional cardiologists in settings with the necessary infrastructure and post-operative care.

New Approvals and Launches
Recent regulatory approvals and launches, including the FDA approval of Medinol’s EluNIR-PERL drug-eluting stent in October 2023 and Abbott’s launch of the XIENCE Sierra Everolimus Eluting Coronary Stent System in India in May 2024, are broadening access to advanced stent platforms.

Global Market Insights

The market is being shaped by the increasing prevalence of cardiovascular disease, driven by ageing populations, sedentary lifestyles, and rising rates of diabetes and obesity. Manufacturers are increasingly focusing on ultrathin designs, bioresorbable scaffolds, dual-therapy stents, and intravascular imaging to optimize stent placement and improve procedural success and long-term outcomes.

Peripheral stents are gaining traction due to the rising incidence of peripheral artery disease, particularly in diabetic and elderly patients, while favorable reimbursement policies, ongoing clinical trials, and dedicated stents for complex anatomies such as bifurcations and below-the-knee lesions are creating new growth opportunities.

North America leads the market, supported by a strong healthcare system, high procedure volumes, and wide use of new stent technology. Europe is the second-largest market, and Asia Pacific is the fastest-growing region.

Explore the Coronary and Peripheral Stents industry overview for additional market insights: https://www.businessmarketinsights.com/industry-overview/coronary-and-peripheral-stents-market

Regional Analysis

North America
North America leads the market, supported by a strong healthcare system, high procedure volumes, strong payment systems, and a large number of cardiac care centers. The report covers the United States, Canada, and Mexico.

Europe
Europe is the second-largest market, supported by robust regulatory frameworks, extensive physician expertise, and a growing preference for minimally invasive procedures. The report covers Germany, Italy, France, the U.K., Spain, Belgium, the Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, the Czech Republic, Ukraine, Slovakia, and Bulgaria.

Asia Pacific
Asia Pacific is expected to grow significantly during the forecast period and is the fastest-growing region. The region benefits from a rising number of heart patients, expanding health budgets, greater use of advanced stents, rapid urbanization, and the emergence of new global and local device manufacturers. The report covers China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Taiwan, and Bangladesh.

South and Central America
The report covers Brazil, Argentina, Chile, Colombia, and Peru.

Middle East and Africa
The report covers Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, and Algeria.

Market Forecast by 2033

The Coronary and Peripheral Stents Market is projected to increase from US$ 9,327.81 million in 2024 to US$ 20,230.87 million by 2033, reflecting an 8.98% CAGR during 2025–2033.

Drug-eluting stents lead by product type, metal leads by material type, coronary artery disease leads by application, and hospitals lead by end user. Asia Pacific is expected to grow significantly through 2033.

Strategic Analysis

Companies operating in the market are focusing on stent design, drug coatings, imaging-guided placement, and broader regional access. Peripheral artery disease and complex anatomies provide opportunities to expand use, while emerging markets provide additional avenues for growth.

Strategic priorities include advancing ultrathin, bioresorbable, and dual-therapy stent technologies, developing dedicated stents for complex anatomies, supporting intravascular imaging, and building presence in Asia Pacific and other emerging markets.

Market Drivers

Growing Adoption of Drug-Eluting Stents
The growing preference for drug-eluting stents is a significant driver. Their drug coating is released slowly over time to prevent re-narrowing of the artery, improving long-term outcomes compared with bare-metal stents. Advances in stent platforms, polymer coatings, and antiproliferative drugs, along with guideline endorsements, positive long-term clinical data, and broader availability in emerging markets, have made them the preferred choice for a wide range of patients.

Rising Prevalence of Coronary and Peripheral Artery Disease
Coronary and peripheral artery disease occur when arteries become clogged with plaque, increasing the risk of serious heart and vascular events. According to the U.S. Centers for Disease Control and Prevention, coronary artery disease is the most common type of heart disease and was responsible for 371,506 deaths in the U.S. in 2022. Rising awareness, earlier diagnosis, and improved access to advanced interventional procedures are increasing stent use in both developed and developing countries.

Market Opportunities

Technological Advances in Stent Design
Ultrathin designs, bioresorbable scaffolds, and dual-therapy stents, together with intravascular imaging to help optimize placement, are expected to continue improving procedural success rates and long-term patient outcomes.

Dedicated Stents for Complex Anatomies and Peripheral Disease
Rising peripheral artery disease, particularly in diabetic and elderly patients, and the introduction of dedicated stents for bifurcations and below-the-knee lesions are opening new areas of growth, supported by favorable reimbursement policies and ongoing clinical trials.

Expanding Access in Emerging Markets
Expanding health budgets, rapid urbanization, and the emergence of new global and local manufacturers are increasing access to advanced stents in growing economies, particularly in Asia Pacific.

Market Restraints

Pricing Pressures
Pricing pressures from healthcare payers and procurement systems can limit revenue growth and market expansion.

Regulatory Challenges
Regulatory requirements for new stent technologies can lengthen development and approval timelines and limit market expansion.

Competitive Landscape

The competitive landscape includes large medical technology companies and specialized cardiovascular device developers.

Key players profiled in the report include:

  • Medtronic plc
  • Boston Scientific Corporation
  • Abbott Laboratories
  • B. Braun SE
  • TERUMO CORPORATION
  • Teleflex Incorporated
  • Lepu Medical Technology(Beijing) Co.,Ltd.
  • W. L. Gore & Associates, Inc.
  • Cook Medical
  • Meril Life Sciences

Get Premium Research Report of Coronary and Peripheral Stents Market Size and Growth Report by 2033 at: https://www.businessmarketinsights.com/buy/BMIPUB00031925

Conclusion

The Coronary and Peripheral Stents Market is positioned for strong growth through 2033 as cardiovascular disease prevalence, adoption of drug-eluting stents, and technology improvements continue to expand. Drug-eluting stents, coronary applications, hospital use, peripheral artery disease treatment, and emerging-market access provide attractive opportunities for industry participants.

Companies that combine advanced stent technologies, dedicated solutions for complex anatomies, imaging-guided procedural support, and a growing presence in Asia Pacific are well positioned to capitalize on future market opportunities.

Related Reading / Reports

  1. Metal Packaging Market: Analysis of metal packaging types, applications, regional demand, and competitive developments.

About Us

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

Contact us:

  • If you have any questions about this report or would like further information, please contact us:
  • Contact person: Ankit Mathur
  • Email: sales@businessmarketinsights.com
  • Phone: +16467917070

    Leave a Comment